190 related articles for article (PubMed ID: 29094728)
1. Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802.
Zheng YM; Wang WF; Li YF; Yu Y; Gao ZB
Acta Pharmacol Sin; 2018 Apr; 39(4):587-596. PubMed ID: 29094728
[TBL] [Abstract][Full Text] [Related]
2. Identification of WB4101, an
Li M; Wu Y; Zou B; Wang X; Li M; Yu H
Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
[TBL] [Abstract][Full Text] [Related]
3. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain.
Deuis JR; Wingerd JS; Winter Z; Durek T; Dekan Z; Sousa SR; Zimmermann K; Hoffmann T; Weidner C; Nassar MA; Alewood PF; Lewis RJ; Vetter I
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999206
[TBL] [Abstract][Full Text] [Related]
4. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker.
Hinckley CA; Kuryshev Y; Sers A; Barre A; Buisson B; Naik H; Hajos M
Mol Pharmacol; 2021 Jan; 99(1):49-59. PubMed ID: 33298520
[TBL] [Abstract][Full Text] [Related]
6. Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.
Eberhardt M; Nakajima J; Klinger AB; Neacsu C; Hühne K; O'Reilly AO; Kist AM; Lampe AK; Fischer K; Gibson J; Nau C; Winterpacht A; Lampert A
J Biol Chem; 2014 Jan; 289(4):1971-80. PubMed ID: 24311784
[TBL] [Abstract][Full Text] [Related]
7. A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels.
Wang L; Hao H; Meng X; Zhang W; Zhang Y; Chai T; Wang X; Gao Z; Zheng Y; Yang J
J Ethnopharmacol; 2024 Aug; 330():118218. PubMed ID: 38677570
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
9. Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7.
Zhang XY; Bi RY; Zhang P; Gan YH
Acta Pharmacol Sin; 2018 Nov; 39(11):1716-1724. PubMed ID: 29950616
[TBL] [Abstract][Full Text] [Related]
10. µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
Zhang YX; Peng DZ; Zhang QF; Huang B; Yang QC; Tang DF; Chen MZ; Rong MQ; Liu ZH
Acta Pharmacol Sin; 2019 Jul; 40(7):859-866. PubMed ID: 30382183
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Nav1.7 channels by methyl eugenol as a mechanism underlying its antinociceptive and anesthetic actions.
Wang ZJ; Tabakoff B; Levinson SR; Heinbockel T
Acta Pharmacol Sin; 2015 Jul; 36(7):791-9. PubMed ID: 26051112
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
Liu Z; Cai T; Zhu Q; Deng M; Li J; Zhou X; Zhang F; Li D; Li J; Liu Y; Hu W; Liang S
J Biol Chem; 2013 Jul; 288(28):20392-403. PubMed ID: 23703613
[TBL] [Abstract][Full Text] [Related]
14. Biphasic voltage-dependent inactivation of human Na
Godazgar M; Zhang Q; Chibalina MV; Rorsman P
J Physiol; 2018 May; 596(9):1601-1626. PubMed ID: 29441586
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.
Niu HL; Liu YN; Xue DQ; Dong LY; Liu HJ; Wang J; Zheng YL; Zou AR; Shao LM; Wang K
Acta Pharmacol Sin; 2021 Aug; 42(8):1235-1247. PubMed ID: 34103689
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
17. 3'-O-Methylorobol Inhibits the Voltage-Gated Sodium Channel Nav1.7 with Anti-Itch Efficacy in A Histamine-Dependent Itch Mouse Model.
Zhang F; Wu Y; Xue S; Wang S; Zhang C; Cao Z
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31805638
[TBL] [Abstract][Full Text] [Related]
18. p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder.
Suter MR; Bhuiyan ZA; Laedermann CJ; Kuntzer T; Schaller M; Stauffacher MW; Roulet E; Abriel H; Decosterd I; Wider C
Anesthesiology; 2015 Feb; 122(2):414-23. PubMed ID: 25285947
[TBL] [Abstract][Full Text] [Related]
19. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
20. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
